** Genetic testing company GeneDx WGS.O shares slump 41.5% to $68.43 and set for biggest one-day fall on record
** Co posts Q1 rev of $87.1 mln, down 8.6% from last quarter's $95.3 mln
** Reports net loss of $6.5 mln, or 23 cents per share, in Q1
** WGS, however, beats analysts' estimates for Q1 results and forecasts full-year revenue above estimates- LSEG data
** Three out of 6 analysts rate stock as "buy" or higher, 3 "hold"; Median PT is $109.50
** At last close, WGS was trading at over two-year high of $117.75
** Including session's moves, WGS down ~11% YTD
(Reporting by Twesha Dikshit)
((Twesha.Dikshit@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.